Brief: Mayne Pharma Says Shawn Patrick O'Brien Stepped Down As CEO, Managing Director
Feb 23 (Reuters) - Mayne Pharma Group Ltd MYX.AX: MAYNE PHARMA MANAGEMENT CHANGES SHAWN PATRICK O'BRIEN STEPPED DOWN AS CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR AARON GRAY APPOINTED CHIEF EXECUTIVE OFFICER Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)